Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxic mold: phantom risk vs science.

Jean A Chapman1, Abba I Terr, Robert L Jacobs

  • 1University of California Medical Center, San Francisco, California, USA. jachapmn@swbellnet

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|October 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber.

Allergy and asthma proceedings·2022
Same author

Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma.

Allergy·2021
Same author

Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.

Allergy·2021
Same author

Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases.

The Journal of allergy and clinical immunology·2021
Same author

Olopatadine-mometasone combination nasal spray: Evaluation of efficacy and safety in patients with seasonal allergic rhinitis.

Allergy and asthma proceedings·2019
Same author

Frequency of goose and duck down causation of hypersensitivity pneumonitis within an 80-patient cohort.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2019

Fungal contamination in buildings can cause irritation, allergies, or infections. However, building-related illness from mycotoxicosis remains unproven, emphasizing prompt remediation of water-damaged areas.

Area of Science:

  • Environmental Health
  • Mycology
  • Toxicology

Background:

  • Fungi, commonly known as molds, are ubiquitous in indoor environments.
  • Concerns exist regarding their potential health impacts, necessitating a scientific review of available data.

Purpose of the Study:

  • To critically review the scientific literature on fungi (molds) and their health effects.
  • To differentiate scientifically validated information from unproved and controversial claims regarding mold-related illnesses.

Main Methods:

  • A comprehensive literature review synthesizing existing research on toxic mold issues.
  • Inclusion of authors' clinical experience with patients reporting mold-related illnesses.
  • Critical appraisal of pertinent scientific investigations and previously published reviews.

Related Experiment Videos

Main Results:

  • Indoor mold presence does not automatically imply occupant exposure.
  • Antibodies (IgE or IgG) indicate fungal exposure but not necessarily illness.
  • Mold-related diseases are categorized into noncontroversial (irritation, allergy, infection) and controversial (mycotoxicosis) disorders.

Conclusions:

  • Mold-related symptoms are typically transient irritation, allergy, or infection.
  • No definitive proof of building-related illness due to mycotoxicosis exists in medical literature.
  • Immediate remediation of water damage and infrastructure repair are the recommended primary responses to fungal contamination.